Sugi Predict

Sugi Predict / Compounds / Cyclopentene

Cyclopentene

Cyclopentene

SCHEMBL4933266

C1=CCCC1.CCC(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ FFAR3 O14843 2/20 0.56
▸ HDAC3 O15379 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ BBOX1 O75936 2/20 0.32
▸ CYP2C19 P33261 1/20 0.31
▸ AKR1B1 P15121 1/20 0.31
▸ THRA P10827 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ EPHX1 P07099 1/20 0.30
▸ CES2 O00748 1/20 0.30
▸ CES1 P23141 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4983371 0.94 FFAR3 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexene SCHEMBL3146768 0.94 FFAR3 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Propionic Acid SCHEMBL4983364 0.94 FFAR3 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL4093030 0.82 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclopentane SCHEMBL97373 0.82 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclohexane SCHEMBL2585876 0.82 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Propionic Acid SCHEMBL5062880 0.82 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclopentane SCHEMBL28987168 0.82 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Cyclooctane SCHEMBL27748002 0.82 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8
Propionic Acid SCHEMBL29094849 0.82 FFAR3 (0.83) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116354792-B Method for preparing cyclopentanol from cyclopentene 福州大学 2024-06-04 — — CN disclosed
CN-116354792-B Method for preparing cyclopentanol from cyclopentene 福州大学 2024-06-04 — — CN disclosed
CN-116354792-A Method for preparing cyclopentanol from cyclopentene and working method thereof 福州大学 2023-06-30 — — CN disclosed
CN-116354792-A Method for preparing cyclopentanol from cyclopentene and working method thereof 福州大学 2023-06-30 — — CN disclosed
CN-116003503-A Preparation method of estradiol cyclopentanepropionate 湖北葛店人福药业有限责任公司 2023-04-25 — — CN disclosed
US-20080214542-A1 Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands BIOPROJET (FR) 2008-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214542-A1 Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands SLC6A3, ADRB3, PRLHR FFAR3 113/4885HDAC3 756/4885HDAC1 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.